160 related articles for article (PubMed ID: 3597005)
1. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water.
Montgomery AB; Paajanen H; Brasch RC; Murray JF
Invest Radiol; 1987 May; 22(5):377-81. PubMed ID: 3597005
[TBL] [Abstract][Full Text] [Related]
2. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
Niemi P; Koskinen S; Reisto T
Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
[TBL] [Abstract][Full Text] [Related]
3. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of pulmonary ventilation. Initial experiences with a gadolinium-DTPA-based aerosol.
Misselwitz B; Mühler A; Heinzelmann I; Böck JC; Weinmann HJ
Invest Radiol; 1997 Dec; 32(12):797-801. PubMed ID: 9406020
[TBL] [Abstract][Full Text] [Related]
5. Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium.
Berthezène Y; Mühler A; Lang P; Shames DM; Clément O; Rosenau W; Kuwatsuru R; Brasch RC
J Magn Reson Imaging; 1993; 3(1):125-30. PubMed ID: 8428078
[TBL] [Abstract][Full Text] [Related]
6. The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation.
Braunschweiger PG; Schiffer L; Furmanski P
Magn Reson Imaging; 1986; 4(4):285-91. PubMed ID: 3118123
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
8. Pseudolayering of Gd-DTPA in the urinary bladder.
Elster AD; Sobol WT; Hinson WH
Radiology; 1990 Feb; 174(2):379-81. PubMed ID: 2296649
[TBL] [Abstract][Full Text] [Related]
9. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium cryptelates as MR contrast agents.
Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
[TBL] [Abstract][Full Text] [Related]
11. Metal chelates as urographic contrast agents for magnetic resonance imaging. A comparative study.
Marotti M; Schmiedl U; White D; Ramos E; Johnson T; Engelstad B
Rofo; 1987 Jan; 146(1):89-93. PubMed ID: 3027795
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and clearance of liposomal gadolinium-DTPA.
Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk.
Schaefer S; Malloy CR; Katz J; Parkey RW; Buja LM; Willerson JT; Peshock RM
J Am Coll Cardiol; 1988 Oct; 12(4):1064-72. PubMed ID: 3417979
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
16. Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
Vion-Dury J; Masson S; Devoisselle JM; Sciaky M; Desmoulin F; Confort-Gouny S; Coustaut D; Cozzone PJ
J Pharmacol Exp Ther; 1989 Sep; 250(3):1113-8. PubMed ID: 2778711
[TBL] [Abstract][Full Text] [Related]
17. [Aerosolized gadolinium-DTPA for demonstration of pulmonary ventilation in magnetic resonance tomography].
Haage P; Adam G; Misselwitz B; Karaagac S; Pfeffer JG; Glowinski A; Döhmen S; Tacke J; Günther RW
Rofo; 2000 Apr; 172(4):323-8. PubMed ID: 10961215
[TBL] [Abstract][Full Text] [Related]
18. In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA.
Lee H; Price RR; Holburn GE; Partain CL; Adams MD; Cacheris WP
J Magn Reson Imaging; 1994; 4(4):609-13. PubMed ID: 7949689
[TBL] [Abstract][Full Text] [Related]
19. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.
Strich G; Hagan PL; Gerber KH; Slutsky RA
Radiology; 1985 Mar; 154(3):723-6. PubMed ID: 3969477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
